Live Chat ×
Skip to main content

Snapshot of MDS: Key Findings and Implications for Patients

During this program, recorded on November 15, 2016, Dr. Park (NYU Langone Medical Center) discusses what is on the horizon in MDS research for 2017. Dr. Park will also talk about the difference between cytogenetics and epigenetics in relation to MDS. He further discusses the role of genetic testing, explains the implications for MDS patients and how this will affect treatment plans in the future.

By the end of this program, you will understand:

  • The difference between epigenetics and cytogenetics
  • The role of genetic testing in MDS
To download the transcript for this program:
  • Click the presentation link down below
  • Select Resources tab
  • Download PDF of transcription
This webinar was brought to you by Celgene Corporation